Department of Nuclear Medicine

Organization profile

Organisation profile

Nuclear medicine is a branch of medicine that uses the pharmaceuticals labeled with radionuclides (radiopharmaceuticals) in diagnosis and therapy. In diagnosis, radioactive substances are administered to patients and the radiation emitted is measured by gamma cameras. In therapy, radionuclides are administered to treat disease or provide palliative pain relief. Nuclear medicine differs from most other imaging modalities in that the tests primarily show the physiological function of the system being investigated as opposed to the anatomy. Radioimmunoassay (RIA) is a highly sensitive laboratory technique used to measure minute amounts of substances including antigens, hormones, and drugs present in the body. The substance or antigen (a foreign substance in the body that causes antibody production) to be measured is injected into an animal, causing it to produce antibodies. Serum containing the antibodies is withdrawn and treated with a radioactive antigen and later with a nonradioactive antigen. Measurements of the amount of radioactivity are then used to determine the amount of antigen present.

Fingerprint Dive into the research topics where Department of Nuclear Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects

    Research Output

    Automatic Classification of Lymph Node Metastasis in Non-Small-Cell Lung Cancer (NSCLC) Patient on F-18-FDG PET/CT

    Cheng, T. C., Chiu, N. T. & Fang, Y. H., 2020 Jan 1, Future Trends in Biomedical and Health Informatics and Cybersecurity in Medical Devices - Proceedings of the International Conference on Biomedical and Health Informatics, ICBHI 2019. Lin, K-P., Magjarevic, R. & de Carvalho, P. (eds.). Springer, p. 138-142 5 p. (IFMBE Proceedings; vol. 74).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  • 1 Citation (Scopus)

    Parapharyngeal Ganglioneuroma Detected by 18 F-FDG PET/CT in a Patient with Hodgkin Lymphoma

    Yi, W. L., Chen, T. P., Chiu, N-T., Liu, C-H. & Lin, Y. H., 2019 Mar 1, In : Clinical Nuclear Medicine. 44, 3, p. 240-243 4 p.

    Research output: Contribution to journalArticle